Rebecca Wilkins, Divisional Vice President of R&D Neuromodulation at Abbott, discusses the evolving role of deep brain stimulation in Parkinson disease, including patient selection, newer DBS technologies, and integration with emerging therapies.
Rebecca Wilkins
Advertisement
Articles by Rebecca Wilkins
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Case Report Raises Questions About Cardiac Microdystrophin Expression, Safety Monitoring With Duchenne Gene Therapy
2
Solriamfetol Improves Wakefulness and Sleepiness in Chinese Patients With Obstructive Sleep Apnea
3
FDA Accepts NDA, Grants Priority Review to Ecopipam for Pediatric Tourette Syndrome
4
FDA Grants Fast Track Designation to Remlifanserin for Alzheimer Disease Psychosis
5